Crespo, E., Cravedi, P., Martorell, J., Luque, S., Melilli, E., Cruzado, J. M., . . . Bestard, O. (2017). Post-transplant peripheral blood donor-specific IFN-γ ELISPOT assays differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. Kidney Int.
Chicago-стиль цитированияCrespo, Elena, et al. "Post-transplant Peripheral Blood Donor-specific IFN-γ ELISPOT Assays Differentiates Risk of Subclinical Rejection and De Novo Donor-specific Alloantibodies in Kidney Transplant Recipients." Kidney Int 2017.
MLA-цитированиеCrespo, Elena, et al. "Post-transplant Peripheral Blood Donor-specific IFN-γ ELISPOT Assays Differentiates Risk of Subclinical Rejection and De Novo Donor-specific Alloantibodies in Kidney Transplant Recipients." Kidney Int 2017.